Upstream Bio (UPB) Total Current Liabilities (2023 - 2026)

Upstream Bio's Total Current Liabilities history runs 4 years deep, the most recent figure standing at $13.7 million for Q1 2026.

• In Q1 2026, Total Current Liabilities rose 42.88% year-over-year to $13.7 million; the TTM figure through Mar 2026 stood at $13.7 million (up 42.88% YoY), while the FY2025 annual figure was $13.5 million, up 25.29% from the prior year.
• Total Current Liabilities for Q1 2026 stood at $13.7 million, up from $13.5 million in the prior quarter.
• The five-year high for Total Current Liabilities was $13.7 million in Q1 2026, with the low at $6.5 million in Q4 2023.
• The 4-year median for Total Current Liabilities is $10.9 million (2024), against an average of $11.0 million.
• The sharpest annual moves came in 2024 and 2025: Total Current Liabilities jumped 64.8% in 2024, then rose 9.51% in 2025.
• Upstream Bio's Total Current Liabilities stood at $6.5 million in 2023, then surged by 64.8% to $10.7 million in 2024, then climbed by 25.29% to $13.5 million in 2025, then gained by 1.61% to $13.7 million in 2026.
• Business Quant data shows UPB's Total Current Liabilities at $13.7 million in Q1 2026, $13.5 million in Q4 2025, and $11.9 million in Q3 2025.